THERALASE INC.

Theralase Technologies Inc. is a clinical-stage pharmaceutical and medical device company founded in 1994, headquartered in Toronto, Canada. The company specializes in the research, development, manufacturing, and commercialization of patented laser technologies and light-activated photodynamic compounds (PDCs) for cancer treatment, bacterial and viral elimination, and chronic pain management. Theralase operates two primary divisions: the Drug Division develops light-activated PDCs and drug formulations for oncology and infectious disease applications; the Device Division manufactures proprietary super-pulsed laser systems for therapeutic use. Core technology platforms include Anti-Cancer Therapy (ACT), a non-invasive light-activated photodynamic approach targeting cancer cells, and Cool Laser Therapy (CLT), a low-level laser system designed for chronic knee pain relief and tissue healing. The company markets to healthcare practitioners and medical institutions across North America and internationally, serving oncology, pain management, physiotherapy, and veterinary sectors.